Tango Therapeutics, Inc. (TNGX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TNGX. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 12,438,444 | $389M | INCREASED |
| State Street | 5,979,806 | $187M | INCREASED |
| Pictet Asset Management Holding | 582,262 | $18M | NEW |
| Fisher Asset Management | 578,158 | $18M | INCREASED |
| BNY Mellon | 390,920 | $12M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Adam Crystal (President, R&D) | EXERCISE | 27,000 | $140K | 2026-08-03 |
| Adam Crystal (President, R&D) | SELL | 21,733 | $594K | 2026-08-03 |
| Adam Crystal (President, R&D) | SELL | 5,267 | $141K | 2026-08-03 |
| Adam Crystal (President, R&D) | EXERCISE | 27,000 | $140K | 2026-07-01 |
| Adam Crystal (President, R&D) | SELL | 7,371 | $223K | 2026-07-01 |
Full institutional holdings, insider history, and congressional trades for Tango Therapeutics, Inc. on SentiSense.